Work from our lab has recently shown that CSF TDP-43 combined with tau proteins in the TDP-43 × t-tau/p-tau formula has good sensitivity and specificity for the discrimination of ALS-FTD spectrum disorders from controls [149,150,151]. The gene discussed is MAPT; the disease is amyotrophic lateral sclerosis.